TOP TIERMARKET NEWSWIRE
News & sentiment

VIR BIOTECHNOLOGY IN (VIR) — News & AI sentiment

VIR BIOTECHNOLOGY IN (VIR) news roundup. 8 stories in the last 24 hours, 38 in the past week, 56 over 30 days. Average 24-hour sentiment is 29/100 — bearish-leaning (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $42K — net selling of $42K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
8
avg sentiment 29/100
7d stories
38
avg sentiment 54.4/100
30d stories
56
avg sentiment 54.1/100
Insider net (90d)
$42K
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

VIR news in the last 24 hours, 7 days, 30 days and 90 days

How much VIR coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowVIR storiesAvg AI sentimentRead
Last 24 hours829/100VIR headlines →
Last 7 days3854.4/100VIR headlines →
Last 30 days5654.1/100VIR headlines →
Last 90 days7856/100VIR headlines →

Latest stories on VIR

Vir Biotechnology falls -17.6%
The Fly22 · bearishgeneral
8h ago
Vir Biotechnology falls -16.6%
The Fly28 · bearishgeneral
10h ago
11h ago
Why is Vir Biotechnology stock tumbling today?
Investing.com Markets34 · bearishgeneral
12h ago
13h ago
15h ago
15h ago
23h ago
1d ago
1d ago
1d ago
1d ago
1d ago
3d ago
3d ago
3d ago
3d ago
3d ago
4d ago
4d ago
4d ago
4d ago
4d ago
Vir Biotechnology, Inc. (VIR) files 8-K
SEC 8-K50 · neutralgeneral
4d ago
5d ago
Open VIR in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →